Sempra Energy Is One Of The Fastest Growing Utilities

Sempra Energy stock chart shows the biggest positive divergence between large players volume and price so far in 2018. However, the financial health of the company is in question after the Oncor Electric takeover.

Sempra Energy is one of the fastest growing utilities in the industry. Sempra Energy is merging with Oncor Electric which is expected to improve earnings and revenue growth. But there's so much more to like about this stock.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Ablynx Stock Explodes Higher As Large Players Volume Rises

Ablynx stock is a late-stage clinical development company that is finally going to bring a product to market in Germany in 2018.

Summary

  • 2018 is the year that Ablynx brings Caplacizumab to market in Germany.
  • Novo Nordisk made an unsolicited bid for the company that was rejected.
  • Large players volume and the Twiggs Money Flow are surging higher.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Ampliphi Biosciences Stock 770% Upside From Current Price

    Ampliphi Biosciences stock has rising large players volume after the company released incredible phase 1 trial results from their phage therapy cure for antibiotic resistant superbugs.

    Summary

  • Antibiotic resistant superbugs are on the rise killing more than 23,000 Americans each year.
  • By 2050, 10 million people will die each year from infections that are curable today like ear and paper-cut infections.
  • Phage therapy can kill superbugs but still needs lots of work and FDA approval.
  • Ampliphi Biosciences is conducting several phage therapy clinical trials in 2018.
  • Large players volume is rising in Ampliphi Biosciences stock after incredible clinical trial data was released in early January 2018.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Motif Bio’s Antibiotic Resistant Drug and Stock Turnaround

    Motif Bio stock is a high risk, high reward gambit on iclaprim, an antibiotic drug that can kill antibiotic resistant bacteria.

    Summary

  • Motif Bio has developed a bacteria killer using a new approach that could help the drug overcome antibiotic resistance.
  • Iclaprim had solid Phase 3 trial data that demonstrated non-inferiority for all primary endpoints.
  • Large players volume is rising.
  • This is a high, risk high reward gambit.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Winnebago Industries Stock Consolidation Setup

    Winnebago Industries stock finally has consolidated setting up for a compelling long entry. Growth in the towables RV market has exploded higher.

    Summary

  • Winnebago Industries grew revenue by more than 70% last quarter.
  • Winnebago is experiencing high-growth rates in their towables product line.
  • Winnebago stock has finally pulled back and looks like a good long entry.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Medidata Solutions Stock Is a Growth Play on Rising Large Players Volume

    Medidata Solutions stock has rising large players volume as the weekly chart forms a Descending Wedge at key support.

    Summary

  • Medidata Solutions gets big business from the Medical Research Collaborating Center in South Korea.
  • Faster FDA approval times and less regulations mean the number of clinical trials will continue to trend higher.
  • Medidata Solutions is a rapidly growing company with revenue growing by 19.35% on average over the past 5 years.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Penske Automotive Expanding Into UK With Acquisitions

    Penske Automotive is on an aggressive expansion strategy through acquisitions. The company’s latest acquisition is in the U.K.

    Summary

  • Penske is on an aggressive acquisitions spree to improve top-line growth.
  • Expansion into U.K. markets is a good move for Penske.
  • Penske's stock is a bit extended to the upside. I prefer stalking for a consolidation entry.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Agilent Acquires Luxcel Biosciences

    Agilent stock is up heading into the announcement that the company acquired Luxcel Biosciences. I think the stock has run up too far to be a good entry right now.

    Agilent Technologies has acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based from vitro cell assay kits. This acquisition expands Agilent's cell evaluation portfolio with the inclusion of easy-to-use assay kits which are compatible with industry standard plate-readers.

    TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    AbbVie Stock Chart Shows Pocket Pivot Cluster On FDA Breakthrough Therapy

    Abbvie stock is a good long-term buy and hold on a “dream-team” pipeline of phase 3 trials.

    Summary

  • AbbVie just received breakthrough therapy designation from the FDA for JAK1 inhibitor.
  • The company has a robust pipeline of drugs in phase 3 trials.
  • Over the last 5 years, revenue has been growing by 8.21% per year.
  • AbbVie stock has a bullish pocket pivot cluster with positive Twiggs Money Flow.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Starwood Property Trust Stock Oversold Bounce On Florida Expansion

    Starwood Property Trust stock is a good play on rising interest rates. The company’s stock is oversold and it pays out a dividend of more than 9% annual yield.

    Summary

  • Starwood Property Trust stock has sold off setting up an attractive valuation.
  • The company pays a whopping 9% annual dividend yield.
  • Starwood Property has just made a huge acquisition of 28 multifamily properties in Florida.
  • Starwood Property is a good directional-play on rising interest rates.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.